The company
United Therapeutics Corporation
UTHR · Nasdaq
UTHR stood above a rising 150-day average in 40 of the last 52 weekly readings, including each of the last 2 weeks. It is 0.5% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $1.7M
- Insider sales, 12 months
- $2.5B
- Officials’ trades on record
- 7
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 40 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
7 disclosed lines: House 6, Senate 0, executive 1; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Jun 2026filed 22 Aug 2026 |
| Lisa C. McClain House: U.S. House ClerkMI09 | soldspouse | $1k–$15k | 31 Oct 2025filed 21 Nov 2025 |
| Lisa C. McClain House: U.S. House ClerkMI09 | boughtspouse | $1k–$15k | 30 Oct 2025filed 21 Nov 2025 |
| Lisa C. McClain House: U.S. House ClerkMI09 | soldspouse | $1k–$15k | 30 Oct 2025filed 21 Nov 2025 |
| Lisa C. McClain House: U.S. House ClerkMI09 | boughtspouse | $1k–$15k | 11 Jun 2025filed 13 Aug 2025 |
| Donna E. Shalala House: U.S. House ClerkFL27 | sold | $1k–$15k | 6 Mar 2019filed 27 Apr 2020 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $1k–$15k | 27 May 2015filed 7 Jun 2015 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Martine A. RothblattChairperson & CEO | sold | 160at $534.75 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 360at $536.36 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 240at $537.11 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 160at $538.54 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 880at $539.79 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 1,800at $540.63 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 520at $541.38 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 260at $542.81 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 1,240at $543.73 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 1,040at $544.89 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 1,065at $545.90 | 19 Oct 2026filed 20 Oct 2026 |
| Martine A. RothblattChairperson & CEO | sold | 416at $547.00 | 19 Oct 2026filed 20 Oct 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.